Portfolio company
Confluence Life Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops kinase inhibitors to treat inflammatory disorders and cancer for pharmaceutical and biotechnology industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BCI Pharma
This biotech company develops selective kinase inhibitors and chemical libraries for pharmaceutical partners to treat cancer, inflammation and women's health conditions.
Kanvas Biosciences
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
BioMoti
This company develops targeted drug delivery technology for cancer therapeutics, primarily serving the pharmaceutical and biotechnology industries.
Commit Biologics
This biotechnology firm develops a platform for creating bispecific complement engagers to treat cancer and autoimmune diseases for the pharmaceutical industry.
Apini Therapeutics
This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.
Complix
This company develops protein therapeutics based on its alphabody technology to treat cancer, viral diseases and autoimmune conditions for the pharmaceutical industry.
Conveyor Therapeutics
This biotech company develops antibody drug conjugates to deliver immunosuppressive payloads for the treatment of immunological and inflammatory diseases in human patients.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
